Therefore, in our study, the expression of HCG11 and its potential target miR-579-3p/MDM2 were analyzed in clinical pancreatic carcinoma and corresponding para-carcinoma tissues. This evidence concerns the gene HCG11 and exocrine pancreatic carcinoma.